NCT05343156View on ClinicalTrials.gov

Efficacy and Safety of Dexamethasone Nanoparticles Eye Drops in Diabetic Macular Edema

PHASE2CompletedINTERVENTIONAL

Enrollment

144

Participants

Timeline

Start Date

September 18, 2017

Primary Completion Date

March 28, 2019

Study Completion Date

March 28, 2019

Conditions

Diabetic Macular Edema

Interventions

DRUG

Dexamethasone nanoparticles eye drops

DexNP 15 mg/mL eye drops 3 times a day (every 8 hours) for 12 weeks

Trial Locations (1)

2600

Glostrup Hospital, Glostrup Municipality

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Oculis

INDUSTRY